|
US20020153508A1
(en)
|
2000-06-29 |
2002-10-24 |
Lynch Matthew Lawrence |
Cubic liquid crystalline compositions and methods for their preparation
|
|
US6887487B2
(en)
*
|
2001-10-19 |
2005-05-03 |
Idexx Laboratories, Inc. |
Injectable compositions for the controlled delivery of pharmacologically active compound
|
|
US6946137B2
(en)
*
|
2001-10-19 |
2005-09-20 |
Idexx Laboratories, Inc. |
Methods for the controlled delivery of pharmacologically active compounds
|
|
US7439268B2
(en)
*
|
2003-07-18 |
2008-10-21 |
Idexx Laboratories |
Compositions containing prodrugs of florfenicol and methods of use
|
|
US20050049210A1
(en)
*
|
2003-08-27 |
2005-03-03 |
Idexx Laboratories, Inc. |
Methods for the controlled delivery of pharmacologically active compounds
|
|
SG173326A1
(en)
*
|
2004-06-04 |
2011-08-29 |
Camurus Ab |
Liquid depot formulations
|
|
US9012506B2
(en)
|
2004-09-28 |
2015-04-21 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
|
US9000040B2
(en)
|
2004-09-28 |
2015-04-07 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
|
WO2006036983A2
(en)
|
2004-09-28 |
2006-04-06 |
Atrium Medical Corporation |
Pre-dried drug delivery coating for use with a stent
|
|
US8124127B2
(en)
|
2005-10-15 |
2012-02-28 |
Atrium Medical Corporation |
Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
|
|
WO2006036964A2
(en)
|
2004-09-28 |
2006-04-06 |
Atrium Medical Corporation |
Barrier layer
|
|
US9801982B2
(en)
|
2004-09-28 |
2017-10-31 |
Atrium Medical Corporation |
Implantable barrier device
|
|
US20060127437A1
(en)
*
|
2004-12-13 |
2006-06-15 |
Misty Anderson Kennedy |
Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
|
|
US20070059350A1
(en)
*
|
2004-12-13 |
2007-03-15 |
Kennedy John P |
Agents for controlling biological fluids and methods of use thereof
|
|
US8535709B2
(en)
*
|
2004-12-13 |
2013-09-17 |
Southeastern Medical Technologies, Llc |
Agents for controlling biological fluids and methods of use thereof
|
|
US8288348B2
(en)
*
|
2005-07-13 |
2012-10-16 |
Allergan, Inc. |
Cyclosporin compositions
|
|
US9427423B2
(en)
|
2009-03-10 |
2016-08-30 |
Atrium Medical Corporation |
Fatty-acid based particles
|
|
US8574627B2
(en)
|
2006-11-06 |
2013-11-05 |
Atrium Medical Corporation |
Coated surgical mesh
|
|
US9278161B2
(en)
|
2005-09-28 |
2016-03-08 |
Atrium Medical Corporation |
Tissue-separating fatty acid adhesion barrier
|
|
US9492596B2
(en)
|
2006-11-06 |
2016-11-15 |
Atrium Medical Corporation |
Barrier layer with underlying medical device and one or more reinforcing support structures
|
|
US7550625B2
(en)
*
|
2007-10-19 |
2009-06-23 |
Idexx Laboratories |
Esters of florfenicol
|
|
EP2393472B1
(en)
|
2008-12-05 |
2019-06-05 |
NanoMed Holdings Pty Ltd |
Amphiphile prodrugs
|
|
US20110038910A1
(en)
|
2009-08-11 |
2011-02-17 |
Atrium Medical Corporation |
Anti-infective antimicrobial-containing biomaterials
|
|
WO2011050388A1
(en)
*
|
2009-10-30 |
2011-05-05 |
Monash University |
Liquid crystal composition and method of use
|
|
KR101663551B1
(ko)
*
|
2010-05-18 |
2016-10-07 |
후지필름 가부시키가이샤 |
카로티노이드 함유 조성물 및 그 제조 방법
|
|
WO2012009707A2
(en)
|
2010-07-16 |
2012-01-19 |
Atrium Medical Corporation |
Composition and methods for altering the rate of hydrolysis of cured oil-based materials
|
|
US9867880B2
(en)
|
2012-06-13 |
2018-01-16 |
Atrium Medical Corporation |
Cured oil-hydrogel biomaterial compositions for controlled drug delivery
|
|
LT2877155T
(lt)
|
2012-07-26 |
2021-02-25 |
Camurus Ab |
Opioidų vaisto formos
|
|
PL2877155T3
(pl)
|
2012-07-26 |
2021-05-17 |
Camurus Ab |
Formulacje opioidowe
|
|
MX391097B
(es)
|
2017-11-27 |
2025-03-21 |
Umecrine Cognition Ab |
FORMULACIÓN FARMACÉUTICA DE 3A-ETINIL-3ß-HIDROXIANDROSTAN-17-ONA OXIMA.
|
|
CN113166189A
(zh)
|
2018-04-26 |
2021-07-23 |
纳米医学控股有限公司 |
吉西他滨两亲性前体药物
|
|
SG11202107877WA
(en)
|
2018-06-21 |
2021-08-30 |
NanoMed Holdings Pty Ltd |
Platinum-based amphiphile prodrugs
|
|
US20240083107A1
(en)
*
|
2021-01-29 |
2024-03-14 |
Ioi Oleo Gmbh |
Polyglycerol fatty acid ester-containing composition
|